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Background: Funding agencies constitute one essential pillar for policy makers, researchers and health service
delivery institutions. Such agencies are increasingly providing support for science implementation. In this paper, we
investigate health research funding agencies and how they support the integration of science into policy, and of
science into practice, and vice versa.
Methods: We selected six countries: Australia, The Netherlands, France, Canada, England and the United States. For
13 funding agencies, we compared their intentions to support, their actions related to science integration into
policy and practice, and the reported benefits of this integration. We did a qualitative content analysis of the
reports and information provided on the funding agencies’ websites.
Results: Most funding agencies emphasized the importance of science integration into policy and practice in their
strategic orientation, and stated how this integration was structured. Their funding activities were embedded in the
push, pull, or linkage/exchange knowledge transfer model. However, few program funding efforts were based on
all three models. The agencies reported more often on the benefits of integration on practice, rather than on
policy. External programs that were funded largely covered science integration into policy and practice at the end
of grant stage, while overlooking the initial stages. Finally, external funding actions were more prominent than
internally initiated bridging activities and training activities on such integration.
Conclusions: This paper contributes to research on science implementation because it goes beyond the two
community model of researchers versus end users, to include funding agencies. Users of knowledge may be end
users in health organizations like hospitals; civil servants assigned to decision making positions within funding
agencies; civil servants outside of the Ministry of Health, such as the Ministry of the Environment; politicians
deciding on health-related legislation; or even university researchers whose work builds on previous research. This
heterogeneous sample of users may require different user-specific mechanisms for research initiation, development
and dissemination. This paper builds the foundation for further discussion on science implementation from the
perspective of funding agencies in the health field. In general, case studies can help in identifying best practices for
evidence-informed decision making.
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A key challenge facing health services research and sci-
ence policy is understanding and optimizing the integra-
tion of science into both policy and the practices of
professionals. This paper investigates how health re-
search funding agencies support the integration of sci-
ence into policy and practice.
First, there is confusion and misunderstanding about
terms such as knowledge transfer, knowledge translation,
implementation and research utilization, and even more
so, about such concepts as ‘moving knowledge into action’
[1]. This has led to calls for an improved understanding of
the uses of research [2]. Only a few fields of research—
notably health service research [3-9] and knowledge trans-
fer research [10,11]—have investigated science integration
into policy and practice (SIPP). In fact, health services re-
search, especially research concerned with the use and im-
plementation of research results in policy, has become so
intertwined with the field of knowledge transfer that calls
for efforts have been made to compare and clarify terms
used in the two fields.
Knowledge transfer spans a number of different fields,
including communication with the public, communica-
tion with media, and collaborative approaches to science.
In this paper, the main focus is the direct integration of
science into decision making, both in policy and prac-
tice. We do not examine the indirect influences of sci-
ence on policy making, such as lobbying activities and
public opinion. Rather, we focus on evidence-informed
decision making aimed at modifying policy and practice,
such as SIPP and methods prior to SIPP in the process
[12]. The line separating knowledge transfer and know-
ledge translation is unclear, with some authors advocat-
ing that concepts like technology transfer, continuing
education and commercialization not be included under
these terms [13]. We will not enter into this debate here;
rather, we will focus on the importance of research-
based knowledge in the decision-making process at the
level of both policy and practice.
In the 1970s, concern over knowledge-based decision
making increased among researchers. Research utilization
[14] encompasses conceptual use, instrumental use and
strategic purposeful use. Organizations—funding agencies
in particular—have been interested in licensing, acquiring,
and commercializing biomedical discoveries for years. Re-
cently, stakeholders have championed the integration of
health-related sciences, human sciences, and biomedical
sciences into policy and practice. Dedicated funding, the
identification of strategic objectives, and the implementa-
tion of internal activities within funding agencies all foster
SIPP. In the literature on science policy, or how the pol-
icies of national governments, supranational organiza-
tions, public science funding organizations, and large
public research organizations aimed at influencing theproduction of scientific knowledge [15],’ funding agencies
have been analyzed [12,16,17].
How science policies for SIPP are ingrained in the re-
search agenda at the national level [18-20], how they are
adjusted to the educational sphere [21], how they are
formatted under external pressures [22], and how they
are included in citizen and democratic procedures are all
important issues. The dialogue around, and actions
aimed at, producing stronger investigative SIPP research
highlights two elements: the need to consider other key
players beyond just scientists and policy makers, and the
benefits of understanding the influence of scrutinizing
institutions on the role of science in policy making [23].
This paper identifies funding agencies as a key player and
contributor to SIPP. This premise means we need to study
funding agencies more closely. Not only do we need to see
them as a key player, as already suggested by Sutherland
[23], we need to study their role as a central element, rather
than just one variable in the overall dynamics of SIPP.
This paper is innovative in several ways: it focuses on
funding agencies as a key player in SIPP rather than just
a component of the outside environment as previous au-
thors have done [12,16,17]; it compares funding agencies
on SIPP and examines the policy and practice achieve-
ments of program funding; it expands the traditional
conceptualization that knowledge transfer is centered
around practitioners, policy makers, and academics; it
adds to the growing trend for research focused on policy
integration in the broader framework of health service
research; and it focuses on ‘the external social structures
and processes that influence individual knowing and the
production of collective knowledge’ [24].
In Western countries, the agendas of funding agencies
prioritize national research and orchestrate research
funds to answer current and emerging health challenges
that have the potential to improve the health of their
populations. Funding agencies constitute operational pil-
lars for policy makers, researchers, and service delivery
institutions like hospitals and health departments. This
paper investigates the role of funding agencies in SIPP.
We provide an overview of the knowledge translation
mechanisms of funding agencies as it relates to the
health sector. There is a need to identify and discuss the
challenges to integrating research into policy and into
practice in a timely manner, and to enhance the integra-
tion of research findings into policy—at the macro, local
and in practices at the micro levels.
To date, a few empirical studies have provided details
about SIPP funding: most notably, a study that com-
pared European health services research at the national
level [5], and another that compared health research
funding at the agency level [25]. Both studies relied on a
small number of informants. In the first study, 34 coun-
tries were surveyed in 2007 to 2011, while in the second,
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and 2004. Both studies presented results from an in-
depth analysis of official funding agency documents. The
European comparisons mainly looked at both public and
private funds, policy making, and the activities being
promoted. In our study, we examine these aspects, but
also add the documented benefits of funding, both in
and outside of the policy domain. We include ‘internal’
SIPP orientation strategies by funding agencies, along
with agency activities that support the innovation cycle
for beneficiaries of funds. We present a comparative,
international analysis of the funding agencies’ require-
ments, funding strategies, and the types of activities they
fund. Therefore, this paper continues the international
focus, while also examining the role that funding agen-
cies play in SIPP. It also contributes to the literature on
SIPP by emphasizing health research funding agencies
and inward strategic positioning, all while serving to
bring the current literature up to date.
The overall objective of this paper is to determine
what are the intentions, actions, and benefits of the inte-
gration of science into policy and practice in health-
related funding agencies throughout the world. Our
comparisons will help answer questions like: What kind
of visibility do funding agencies give to SIPP? How do
funding agencies promote SIPP? What impacts do fund-
ing agencies have on practice and policy?
Methods
Selection of funding agencies
We selected funding agencies from six countries: Australia,
The Netherlands, France, Canada, England, and the
Unites States. The agency had to be national or supra-
national in scope, fund health-related research, and a
major provider of research funds. We questioned pro-
fessors, researchers, members of funding agencies,
managers and health service providers who were mobi-
lized to identify the characteristics of the major provider
of research funds category, identifying the ‘contrast or
continuum on knowledge translation engagement’ [25].
Granting councils are:
Australia
National Health and Medical Research Council
(NHMRC)
Australian Research Council (ARC)
The Netherlands
The Netherlands Organization for Health Research and
Development (ZonMW)
France
Institut National de la Santé et de la Recherche
Médicale (INSERM)Centre National de la Recherche Scientifique (CNRS)
Agence Nationale de la Recherche (ANR)
Canada
Canadian Institutes of Health Research (CIHR)
Natural Sciences and Engineering Research Council
(NSERC)
Social Sciences and Humanities Research Council of
Canada (SSHRC)
England
National Institute for Health Research (NIHR)
USA
Food and Drug Administration (FDA)
Environmental Protection Agency (EPA)
National Institutes of Health (NIH)
Data sources
We selected published reports and information provided
on the websites of the selected funding agencies (see
Additional file 1). We extracted information from stra-
tegic plans, mission statements, organizational charts,
reports on available funding for research and internal
productions, success reports, and descriptions of agency
activities. Given that the interest in SIPP is fairly recent,
we restricted our search of key resources to the period
of 2005 to 2011.
The empirical secondary data that we gathered from
these sources was limited: these data do not necessarily re-
flect the most recent and emerging trends in the policies
and decisions being made by funding agencies. To make up
for this limitation, we searched for the latest available and
accessible strategic plans and organizational documents.
Such an approach may have introduced a positive bias and
lead to a more selective discourse disproportionately cen-
tered around ongoing activities and the results obtained for
these particular activities. However, we believe that this bias
is less serious because we are interested in achievements ra-
ther than failures and barriers. We included reports on the
impacts of funding on policy or practices when the data
were detailed and relevant to the grant received. While
source data analysis may not have allowed us to compile in-
formation on all of the internal dynamics of funding, such
dynamics were not our main point of interest.
Using secondary data has the advantages of providing
a level of depth similar from agency to agency, and
sometimes these secondary data have similar categories,
thereby making the comparisons more accurate and
straightforward. The reports and information published
on websites are produced after a review process and ap-
proval by the department responsible for editing and
publishing official data, thereby ensuring a consistent,
shared view on topics of interest and, ultimately a




Action Type of external actions
Type of internal actions
Steps of innovation
Benefits Type of influences
Specific influences on policy
Specific influences on practice
Specific influences on service delivery
Policy refers to orientations taken by funding agencies on knowledge transfer.
Practice refers to the operational translation of programs and activities.
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obtain such a large and diverse dataset any other way: a
single representative from one institution simply could
not have provided such variety in content. We believe
reports and official website information are a useful
dataset for studying SIPP in funding agencies at this
point in the development of research about science inte-
gration into policy and health.
Note that our data collection relied on information
available on the agencies’ websites. The uniformity of
the data published by a particular agency cannot be
guaranteed by our methodology. There is reason to be-
lieve the selected agencies publish data that are not so
different from one another. Indeed, the websites reveal
each agency’s formal representation of its own activ-
ities. Moreover, the information published by agencies
on their websites is directed at the public, researchers,
policy makers, and practitioners. It is their public
portrait.
Our analysis of the websites generated secondary, ter-
tiary, and endless snowball references as a result of navi-
gating the agencies’ websites plus those of linked
agencies and ministries. We pulled documents that were
directly posted on the agencies’ own websites. Relevant
information was either easily accessible via the home-
page, or it was less available, being stored in archives or
identifiable by the title on webpages. We browsed the
whole website, including archives, paying particular at-
tention to webpages related to strategy and funding. Of
course, a key informant in each agency could have vali-
dated the documents we retrieved, but we sought only
to examine documentation.
Identification of variables
We investigated three main variables of SIPP and their
corresponding dimensions (Table 1):
1. Intentions: Health research funding agencies set
health as a priority and then devise ways to support
and foster the integration of science into policy and
practice. We examined the following dimensions of
intentions: organizational visibility of SIPP (absent,
external, internal) and the purpose of SIPP
(management, network, capacity building).
2. Actions: Health research funding agencies organize
both internal and external SIPP-related activities.
Actions are any specific activities by funding
agencies to ensure the materialization of science into
policy and practice, and to encourage evidence-
based or evidence-informed policy or practices. We
examined the following dimensions of actions: type
of external actions (push, pull, linkage and exchange
(L&E) funding), types of internal actions (reinforcing
capability, process, codification), and steps in theinnovation process (synthesis, initiation,
development, end of grant, science, training).
3. Benefits: Funding agencies collect evidence of the
empirical benefits and return on investment for their
funding activities. Benefits are the consequences—
often positive outputs and outcomes—that
contribute to, or are generated by, specifically
targeted SIPP activities. We examined the following
dimensions of benefits: type of influences (policy,
practice, service), specific influences on policy (local,
national, international), specific influences on
practice (improvement, new, modification of
regulations), and specific influences on service
delivery (financial, human, material).
Results
The agencies used a variety of terms and concepts when
talking about SIPP in their strategic and mission state-
ments: testing knowledge, applying knowledge (applica-
tion), transfer, translate research/knowledge, valorization,
knowledge management, put to real-world use, integrate
science and technology, science coordination with prior-
ities, informed policy advice, use of knowledge/utilization
of science, strategic management of licenses, innovation,
mobilizing knowledge, commercialization, evidence-based




The importance and readiness of SIPP for funding agencies
is partially reflected in their organizational charts, mission
statements, and strategic objectives. The organizational
charts sometimes attribute the responsibility of SIPP to dis-
tinct directorates, departments and/or branches (Table 2).
For example, SSHRC has a separate division for knowledge
mobilization and program integration, unlike ARC, which
does not have any specific divisions. Most of the funding
agencies manage their SIPP mission from within; usually it
Table 2 Organizational visibility of SIPP in funding agencies
Visibility Funding agencies
Absent ARC. no specific directions
External INSERM. INSERM Transfert SA a private entity from INSERM
Internal CNRS Direction of innovation and relationships with companies (translation)
ANR. Partnership and competitiveness; investment in the future (translation)
EPA Office of science policy
NIH Office of science policy analysis
CIHR Knowledge translation branch; partnerships and citizen engagement branch; communications and public outreach branch
SSHRC Knowledge mobilization and program integration division
NHMRC Research investment direction/Prog Grants, Knowledge Translation & Capacity Building
NSERC Research partnerships program directorate; research grants and scholarship directorate
For ZonMw and NIHR, we found no data on organizational structure for SIPP. Please note that NIHR does commission research on SIPP through the NHS and the
Health Services and Delivery Research Programme [35].
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or branches. For example, SSHRC has a knowledge
mobilization and program integration division, while
NHMRC has research investment direction a /Know-
ledge Translation & Capacity Building. In France,
INSERM manages some of its SIPP objectives through
a private entity: INSERM Transfer SA. This group is in
charge of putting highly promising biomedical innova-
tions sponsored by INSERM funds into action; it diag-
noses, accompanies, helps manage, protects, and
supports innovations on the way to commercialization.
One could say that INSERM is involved in translational
research rather than knowledge transfer per se, al-
though there needs to be some adoption of knowledge
with partner companies and so this activity qualifies as
knowledge transfer in our analysis.
Purpose of SIPP
Strategic support for SIPP was embedded in various
strategies devoted to management, exchange, and/or
capacity building. SIPP could be narrowed down to man-
agement objectives, in which knowledge informs the de-
velopment or improvement of new practices and getting
a product out on the market. In such cases, the funding
agencies put an operational emphasis on SIPP. For ex-
ample, INSERM placed an emphasis on managing the
transfer of technology:
‘Its principal mission is to coordinate the valorization
of medical innovations from research laboratories’.
[our translation]
Organizational chart: INSERM Transfert SA a private
entity from INSERM
Source: translation. INSERM Transfert mission.
Website.Some of the funding agencies had a broader scope and
emphasized certain processes involved in SIPP. They
favored a flow of information through contacts and ex-
changes between researchers and policy makers. For ex-
ample, CIHR referred to knowledge translation and
insisted on the importance of dynamic and iterative ex-
changes between the two communities:
‘Knowledge translation (KT) is defined as a dynamic
and iterative process […] to improve the health of
Canadians, provide more effective health services and
products and strengthen the health care system. This
process takes place within a complex system of
interactions between researchers and knowledge users
which may vary in intensity, complexity and level of
engagement depending on the nature of the research
and the findings, as well as the needs of the particular
knowledge user’.
Organizational chart: Knowledge translation branch;
partnerships and citizen engagement branch;
communications and public outreach branch
Source: CIHR. DPR 2009–2010.
SIPP may build on the influence it has on policy and
policy makers to increase its influential capacity in the
legislative branch. In Australia, both funding agencies
we studied sought to contribute to individual and
organizational learning: NHMRC by translating know-
ledge to a broad audience in order to improve policy
and practice, and ARC by playing an advisory role in
policy making.
‘Policy: To provide informed high quality policy ad-
vice to Government—through participation in policy
forums and Government reviews, informed stakeholder
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Organizational chart: No specific directions.
Source: ARC. 2010. Strategic Plan 2010–11 to
2012–13.
To summarize, our comparison of the intentions of
funding agencies shows that:
1. Most funding agencies emphasized SIPP through
specific organizational structures;
2. Science was integrated into policy and practice
through various operational means and by direct
support: through improvements to the management
of SIPP, encouraging the flow of information
between actors in SIPP, and improving learning
related to knowledge;
3. The internal structure of the funding agencies,
combined with relevant funds, increased the
likelihood of SIPP.
Analysis of actions
Types of external actions (pull, push and L&E models)
Informed decision making was often conceptualized in
terms of how to encourage mechanisms that would
bring science into the decision-making arena—that is in
a push fashion. The push-pull model of knowledge
translation is famous for distinguishing between mecha-
nisms driven by science (push) and those driven by the
demands of practitioners or policy makers (pull). These
models consider two communities in interaction: the sci-
entific community of researchers and the practice com-
munity of decision-makers, politicians, local community
members, et al. A third model advocates for consider-
ation of interactions that take place along the innovation
cycle and make science useful [26]. Such L&E [10], or
deliberate models, rely on the co-construction of applied
knowledge [27] and the relevance of applied research to
both users and researchers. During research develop-
ment, data collection and interpretation tasks can be
shared. Most of the agencies we examined funded pro-
grams based on one or two of these models, either push,
pull, or L&E. Few provided funding based on all three
types of SIPP models, with the exception of NHMRC,
ZonMW, NSERC and NIHR (Table 3, line 1).
ZonMW’s Ethnic Minorities and Health Care Program
belongs to the push model driven by science:
‘The Ethnic Minorities and Health Care Programme
aims to promote the implementation of knowledge and
skills available in this area. It targets both providers and
users of care. The programme focuses on improving
somatic curative care, an area in which knowledgeand methods are available that could potentially
improve care for ethnic minorities in the
Netherlands. The aim is to spread this knowledge
and these methods, and ensure they become part
of mainstream care’.
NHMRC’s urgent research program reflects a pull
model driven by policy needs:
‘Research that must be undertaken rapidly in response
to a threat to public health. The threat may be
generalised, or specific to a particular group of
individuals, and may be identified as either a current
major problem, a potential major problem or a
problem that is expected to increase in the future.
The main catalysts for urgent research will be the fact
that a disease or illness, or its variant(s), is previously
unknown or unidentified, and has a high morbidity
and/or mortality rate, thus garners media coverage
and public and/or governmental concern. This
definition covers the range of possibilities at the
cellular level (the identification of the disease or
illness, and its variants), to those at the public and
population level, and then the level of risk to a nation.
For example, if a disease poses a probable or actual
threat to the national and/or local economy by
hindering exports, tourism, agriculture, and so on.
The SRDC has outlined a process for considering
requests for urgent research based on this decision’.
ANR’s competitive pole funding program belongs to
the linkage and exchange model:
‘A competitive pole is constituted by companies,
research laboratories and training centers in a
geographic area in order to favor cooperation and
exchange’. [our translation]
In the agencies studied, the creation and development
of research in collaboration with users (L&E model) took
the form of meetings to explore prospective subjects of
interest, on-site training opportunities for practitioners to
come to research settings, and inviting researchers to join
decision making settings. The NIHR in England provided
financial support for partnerships with health service pro-
viders through its Service Delivery and Organization
(SDO), where research results could be presented to prac-
titioners and practitioners could present their needs.
AHSC Academic Health Science Centers have brought to-
gether research units, health care services, and education
institutions, thus promoting cross-fertilization between re-
search and practice.
Funding based on the push model was for the transfer of
existing research to users via publications in peer-reviewed
Table 3 Funding agencies program funds
Line 1. Program funds in a push/pull/linkage and exchange (L&E) model
Push Pull L&E 3 modes
% of funding
agencies
69 62 62 23
Line 2. Eligible expenses per innovation cycle steps
Synthesis Initiation Development End of grant Science Training All steps
% of funding
agencies
38 54 69 77 31 62 23
Line 3. Internal activities related to SIPP
Capabilities Process Codification All 3
% of funding
agencies
85 54 46 46
Line 4. Benefits of funded projects
Policy Practice Service delivery 3 types








15 8 8 31 31 8 8 8 23 8
15 46 23 8
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face dissemination in forums and conferences. For example,
the EPA established a Clean Diesel Emerging Technologies
Program to help companies purchase innovative technolo-
gies to control fleet-related diesel emissions. Technologies
existed. The aim was to make innovative, targeted technolo-
gies available and financially accessible to companies.
In funding based on the pull model, research may be
influenced by decision makers, either by focusing on pri-
orities, emergencies, threats, or an urgent need for data.
For example, an infectious outbreak requires rapid
knowledge and treatment solution, which requires that
research priorities become oriented by decision makers.
Programs that targeted science included the develop-
ment of influenza vaccines (the NIVAREC center funded
by ZonMw), the development of specific, applied know-
ledge (e.g., ZonMw’s Chronic Fatigue Syndrome Pro-
gram, which encompasses the science of chronic fatigue
syndrome, treatment and rehabilitation methods), pro-
grams based on priority areas such as Aboriginal re-
search (SSHERC), and strategic awards (NHMRC).
The funding agencies that we studied all funded either
push, pull, or L&E research (Table 3, line 1). Many agen-
cies funded initiatives based on at least two models
(push and pull), but these projects represented less than
one-third of all documented funding (all models).
Types of internal actions
Internal activities carried out by the agencies themselves
help develop organizational knowledge and SIPP. The in-
ternal activities that we documented varied in nature.
Some activities reinforced capabilities, such as classes and
SIPP training sessions, or helped build organizationalknowledge (capability). Some activities were more dy-
namic and helpful in building organizational knowledge,
such as creating knowledge brokers, forums, and commu-
nities of practice. They put actors into situations where
they could discuss and/or solve problems or become more
comfortable with specific topics or issues; in short, they
helped build organizational knowledge understood as a
process. Other activities favored the provision of opera-
tionalized information through guides and handbooks.
These helped the organization build knowledge understood
as a codification. Capability, process, and codification are
ways to categorize knowledge [28], and an organization can
use any of these as a basis of its actions.
Activities that reinforce capabilities
Most funding agencies offered services that facilitated the
use of evidence-based knowledge in decision making.
Some resources, like online portals, assisted in identifying
and tracking funding opportunities (NHMRC). Three-day
courses or a center for posting reviews allowed researchers
to learn and share experiences (NIHR) and diffuse success
stories, to share ideas and good practices with other grant
applicants and practitioners (ARC, NSERC, CIHR and
INSERM). Publishing lists of licensed innovations created
opportunities for companies to carry out discovery research
(INSERM). And classes, summer schools (CIHR), and lec-
ture sessions for researchers, policy makers, or parliament
members (CIHR, AR) served to train actors for SIPP.
Activities that reinforce processes
Our documentation shows that not only resources, but
also active mechanisms favored SIPP. These mechanisms
put the utilization of science in the decision-making
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and decision makers to interact through networks of
trainees (CIHR), encouraged journalistic interest in science
discoveries through journalism awards (CIHR), enabled
companies to consult groups of research expertise
(INSERM), and allowed professionals to interact through
communities of practices (NHMRC). EPA had policy agree-
ments that allowed for formal liaisoning and the communi-
cation of scientific data to decision makers and official
regional coordinators for research and development.
Activities that reinforce codification
Making formalized knowledge useable relies on inform-
ative and descriptive documents. Summaries of research
results can be translated into useful tools for practitioners,
like the targeted summary of guidelines by NHMRC.
Among informative documents, we also found knowledge
transfer handbooks (CIHR). To translate research findings,
the funding agencies also developed more prescriptive
tools, such as targeted summaries of guidelines (NHMRC)
or specific guidelines (NIH, USA, EPA, USA), and even
rules (EPA, USA), agreements, and policies (NIHR).
In summary, we found that the agencies and ministries
developed a variety of activities, especially capabilities, to
make knowledge useful and useable (Table 3, line 3).
These activities enriched the organizations and enabled
them to use the science and knowledge produced.
Steps of innovation
Funding for eligible expenses through funded programs,
which may be based on a push, pull, or L&E model, may
cover a number of different steps in the innovation cycle
[12]. The first step in innovation is initiation, in which
connections between decision makers and researchers are
established and topics of interest fine-tuned. The second
step is development, in which the research is conducted
and then data collected and analyzed. Then there is syn-
thesis (end of grant), which involves the presentation of
research results to the public through conferences and
written diffusion methods like reports. Sometimes reports
synthesize previous results in the field. Research efforts
may center on either generic research topics, priority
areas, or SIPP itself. An eligible applicant, such as a fellow-
ship candidate, institution or group of actors, may, for ex-
ample, benefit from classes on SIPP or even do a
temporary stay at a federal institution in order to get a dir-
ect feel of how and what is done inside public administra-
tion (CIHR). The goal of such training is to help the
applicant translate research into polity and practices.
The most common steps that were funded in the
agencies we studied were end of grant, research devel-
opment, and training in SIPP (Table 3, line 2). Only
two agencies funded all steps in the innovation cycle.
While development and end-of-grant projects appearedto be more frequently funded than knowledge synthesis
or SIPP training projects, the funding agencies did
sometimes have internal SIPP-related activities that
were not related to funding competitions.
We may draw the following conclusions about the
funding agencies’ involvement in the innovation process:
1. The push, pull and L&E models of knowledge
transfer were each supported by a slight majority of
funding agencies
2. Few of the funding agencies relied on all three
models, meaning that all of the complementary
dynamics of the knowledge processes were not
always covered in their funding efforts;
3. Externally funded programs largely covered SIPP at
the end-of-grant stage of the innovation process,
promoting diffusion in reviews, conferences,
etcetera;
4. Internally developed SIPP activities mainly focused
on providing technical support, such as lectures via
an online portal, and such activities were less
frequent than those aimed at bridging and
translating knowledge.Analysis of benefits
Tracking health service research utilization is not an easy
task [3,29]. Here, we report on SIPP-related success stor-
ies, providing examples, individual cases, and positive re-
sults in which funded activities have led to changes in the
use of resources for service delivery, changes in the pro-
duction of service delivery, or in policy making.Types of benefits
The funding agencies mentioned some benefits for prac-
tice and policy of their SIPP-related support. We did not
find any references to the impact of SIPP-related internal
activities. The granting agencies reported the conse-
quences of SIPP under headings like ‘impact spotlights,’
‘impact stories,’ ‘outcomes,’ and ‘results.’ The benefits
discussed in published reports took two forms: direct re-
sults of the funded research, such as a decrease in the
level of cholesterol in the intervention group, and the
impact of the funded research beyond the immediate
scientific community, such as an influence on decision
making in the form of informing guidelines used to de-
velop a new policy. NHMRC’s Evaluation and Outcomes
Working Committee defines direct results as the know-
ledge creation outcome of research [30].
For the purposes of this research, we are interested in
the indirect outcomes and influences of SIPP benefits.
These benefits encompass both macro and micro issues.
They emerge at the policy level, at the practice/
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clients and the population (Table 3, line 4).
Benefits at the policy level
The modifications of policies by SIPP funding could have
local, national, or international effects (Table 3, line 4).
When the modifications were local, they affected the prac-
tices of groups or organizations. Sometimes national pol-
icies were modified through adjustments to regional or
federal policies. The third type of SIPP influence
was international, whereby the policies of international
institutions or non-governmental organizations made
changes to their policies based on practices elsewhere in
the world.
Benefits at the practice level
Some of the SIPP funds supported operational modifica-
tions aimed at improving processes and procedures.
These mechanisms were sometimes implemented at the
country level (Table 3, line 4). When regulations chan-
ged under the impetus of research data, the result could
be the launch of a brand new process or the alteration
of existing ones. Alterations could be accomplished
through the deletion of outdated information that re-
quires modifications, or though the addition of informa-
tion to improve current practices. The modification or
introduction of a new practice or regulation on practices
should, theoretically, lead to improved service delivery.
For engineering projects that lead to conclusive out-
comes, technologies could be used by other industries,
thereby allowing for the creation of new products, diag-
nostic tools or production lines.
Benefits at the service delivery level
Eventually, research outcomes served as a basis for the
adjustment of services delivered to the population—to
patients, to clients, and to other countries (Table 3, line
4). Service delivery requires human resources, material
resources and financial investment. We documented ad-
justment in all of these types of resources based on evi-
dence gathered in research.
We traced the reported success stories to a number of
different fields: policy making, practice organization, and
service delivery (Table 3, line 4). A common impact of
the funding agencies funds was the adjustment of prac-
tical rather than policy aspects, and science delivery.
The funding agencies, especially those focused on med-
ical development and technology, often reported the
commercialization of research ideas—for example, the
development of vaccines and medical technologies.
While success stories related to SIPP were often re-
ported under sections pertaining to the immediate re-
sults of research, the influence of research on service
delivery, practice, and policy making may not beconsistently gathered through funded projects nor re-
ported in funding agencies like CNRS.
To summarize, our analysis of funding agencies re-
vealed the following:
1. There is evidence of benefits at the policy, practice
and service delivery levels;
2. There is evidence that CIHR publicly documents
SIPP benefits in a more consistent way than do the
other funding agencies studied;
3. There is evidence that the benefits of SIPP on
practice are more common than reported.Discussion and conclusions
Conclusions
The goal of this paper was to address the following
questions: what visibility do funding agencies give to
SIPP? How do funding agencies promote SIPP? What
impacts do funding agencies have on practice and pol-
icy? It is difficult to draw a complete and accurate por-
trait of SIPP due to the diversity of terms being used to
designate knowledge transfer and evidence-informed de-
cision making for policy and practice. This no doubt re-
flects the fact that this is still a field under construction.
Our findings support those of Tetroe et al. [25], who
found that funding agencies from a variety of countries
defined ‘knowledge transfer’ in many different ways [25].
Their results were based on interviews with health re-
search funding agencies, ministries, non-governmental
organizations, researchers, and on an analysis of the
funding and internal activities of the agencies.
Apart from the variety of models, definitions, and
measures that agencies use, there is a need to clarify in-
dividual and organizational brokering interventions [31];
reduce inconsistency in publication dissemination meas-
urement and guidance [32]; and adapt health research
systems to policy makers and to stakeholders’ policy-
making systems [5,33]. We need to take into consider-
ation issues related to researcher autonomy (knowledge,
career based on productivity, employment stability); pol-
icy motivation (agendas, urgent needs, career based on
publicity, re-election); and the closeness of funding
agencies to researchers and policy makers. Based on our
results, we would also add such factors as scarcity of ac-
tivities or funds to cover SIPP, from the early stages all
the way up to the final steps of innovation.
In our study, the importance attributed to SIPP was
revealed through an analysis of how present it was in
the structure of the funding agencies. Some of the agen-
cies defined knowledge translation in their mission state-
ment and corporate objectives, while others did not.
Some agencies created a specific branch, directorate or
department to address SIPP.
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push, pull, and linkage and exchange models. Few of the
funding agencies that we studied offered funding based on
all three of these models. Comparing, between these three
models, how the results of a funded project on a particular
topic is translated into knowledge is worth investigating
further. Indeed, using a combination of all three models
may lead to more significant research utilization than does
favoring one model over another.
While funding agencies emphasized the importance of
SIPP, much work still needs to be done to ensure cover-
age of all models of the knowledge transfer process and
of all steps in the SIPP process. This lack is seen in our
analysis of the programs being funded and in their in-
ternal activities. The benefits obtained from funding
SIPP and from SIPP activities are difficult to measure
and compare because data reporting and collection is
generally not systematic, as others have also noted [5].
Practice integration is largely predominant over policy
integration, which is in line with Kastrinos’ point that
there is ‘a marked trend away from mission-oriented
policies and towards diffusion-oriented policies’ [19].
Funding agencies are becoming more responsive to sci-
ence than they are to policy [34].Study limitations
While some of the funding agencies studied showed a
broad range of internal activities aimed at promoting
SIPP, the published documentation of internal activities,
either through websites or official documentation, was
not consistent across data sources. What is needed is
more comparable data, and the integration of unpub-
lished internal SIPP activities in development. This
paper certainly does not provide an exhaustive list of the
resources or mechanisms available for SIPP. Internal ac-
tivities created within the agencies, or across them, were
not always documented in reports and webpages access-
ible to the public, while pilot activities under develop-
ment were not yet available. Nonetheless, we are
confident that we have covered the sections considered
important by the funding agencies, as such sections are
generally the most clearly identified sections.
The empirical secondary data that we gathered from our
sources are limited: they do not necessarily reflect the
most recent and up-to-date decisions of funding agencies.
We also need to consider that the benefits of research are
mainly self reported by the researchers themselves, and
that these benefits may be the result of either funding for
the execution of research or funding aimed at encouraging
the use of research by stakeholders.
Furthermore, the relationship between the models
(push, pull, and L&E models), or the different steps that
are funded (synthesis, initiation, development, end ofgrant, science of SIPP, training in SIPP), and the actual
results obtained have yet to be investigated. Additionally,
the success stories purporting to demonstrate the actual
integration of science into decision making seemed to
depict the consequences of research results on practice,
and less on service delivery or even policy. Thus, our
analysis probably under represents the extent of internal
activities related to SIPP and underestimates the results
of funding. However, a quality verification across web-
sites and some internal documents reporting on the ac-
tivities of two Canadian institutions, Health Canada and
CIHR, yielded the same general results.
Contributions
This paper makes an important contribution to research
on SIPP because it goes beyond the two community
model, which is based on the conceptualization that re-
searchers produce knowledge and end users utilize
knowledge, to include a variety of actors other than just
producers and users of science. Other authors have
pointed to the importance of having researchers frame
the policy program [7], and to the major roles played by
funding, research and policy actors. We focus on such
issues in a detailed way, examining how science is inte-
grated into policy and practice by an important actor in
this process—funding agencies.
One needs to keep in mind that while in this paper we
have conceptualized producers as researchers from the
scientific community, it is not always easy to make a dis-
tinction between producers and users of science. For ex-
ample, some producers of scientific knowledge work
inside national departments and agencies. Similarly,
users of knowledge for decision making can be found in
a host of different entities: health organizations like hos-
pitals; civil servants assigned to decision making posi-
tions within funding agencies, civil servants outside the
Ministry of Health, such as the Ministry of the Environ-
ment; politicians deciding on health-related legislation;
even university researchers whose work builds on previ-
ous research. This heterogeneous sample of users may
require a host of user-specific mechanisms for the initi-
ation, development and dissemination of research.
This paper sets the foundation for further discussion
on SIPP in funding agencies in the healthcare domain.
We have detailed the complex relationships that exist
between knowledge use in the process of decision mak-
ing at both the policy and practice levels. The other
element—in essence, the flip side—worth investigating is
knowledge development. This aspect, the integration of
policy and practice into science, may be essential if we
are to achieve a meaningful dialogue and reciprocal in-
fluence between research and policy, and between re-
search and practice [7]. Indeed, the production of new
and useable knowledge to improve policy and practice
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and practice integrate into science. Insights for the inte-
gration of policy into science can be learned from previ-
ous studies on the Rothschild initiative in England
[16,17]. Researchers conducted a seven-year formative
evaluation of follow-up data on this attempt by the
English Department of Health in the 1970s to influence
and set the agenda for healthcare research. Recent edito-
rials on collaborative research have highlighted the im-
portance of maintaining an active relationship between
research and the policy and practice side [11].
Case studies are very useful for identifying best practices
in evidence-informed decision making. Of course, the in-
tegration of knowledge/science into practice and policy
does not depend on funding agencies alone [35]. Other or-
ganizations like, for example, Canada’s Policy Research In-
stitute, inform policy, as do government entities like
deputy ministers. In countries like Germany, there are
mechanisms for such integration on advisory boards and
government task forces [5]. Future research could focus
on whether establishing specific priority areas for funding
is more effective in informing decision making than is
funding based on pull, push, or L&E models.
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